Research with Impact

• Overview
• Experience
• Management & Board
• Company History
• Partners

Robert Delghiaccio, Senior Vice President, Business Development

Rob comes to Impact Rx with approximately eighteen years of pharmaceutical industry experience, on both the client and vendor sides of the business. Most recently, he spent almost six years at GfK Healthcare where he was Senior VP, Business Development. His recent successes at GfK include leading a business development and custom research team that was responsible for generating over $21 million in global custom and syndicated market research services. Rob’s market research experience involves uncovering market needs and identifying trends through developing, managing, and analyzing primary and secondary qualitative and quantitative research. He has worked with a variety of data sets while servicing both in-line brand teams and pre-launch compounds at various stages of development. He has also worked with pharma sales operations and helped to create regional/territory sales plans. Rob’s therapeutic areas of expertise include both the gen med arena - Cardiovascular, CNS, Metabolic and Respiratory to name a few, as well as Oncology across a number of tumor types.

Rob began his career at Lilly, in both sales and managed care roles, worked for Merck in Market Research and at Ethicon Endo - a J&J Company. Rob is a graduate of the University of Arizona and received his MBA from Harvard University.